Literature DB >> 1733316

gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis.

J E Schnitzer1.   

Abstract

Albumin reduces capillary permeability and acts as a carrier for various small molecules. Recently, we identified a 60-kDa sialoglycoprotein (gp60) on the surface of cultured rat microvascular endothelial cells (MEC) that binds albumin and antiglycophorin serum (alpha-gp). We verified that alpha-gp recognizes the albumin-binding gp60 by affinity, purifying proteins from MEC extracts using immobilized albumin. gp60 was immunoblotted with alpha-gp only when the MEC extract was reacted with albumin and not in controls. We immunoprecipitated gp60 from biosynthetically radiolabeled MEC lysates and from extracts containing endothelial surface proteins of isolated rat hearts that were radioiodinated in situ. gp60 was immunoblotted selectively in rat tissue microvascular beds lined with continuous endothelium (heart, lung, diaphragm, fat, skeletal muscle, mesentery, and duodenal muscularis but not cortical brain) and not those exclusively lined with fenestrated or sinusoidal endothelium (adrenal, pancreas, liver, and small intestinal mucosa). MEC isolated from rat heart, lung, and epididymal fat pad expressed gp60 and bound albumin, whereas various nonendothelial cells and brain-derived MEC did not. gp60 is an albumin-binding glycoprotein expressed specifically on the surface of continuous endothelium that binds albumin apparently not only to initiate its transcytosis via plasmalemmal vesicles but also to increase capillary permselectivity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733316     DOI: 10.1152/ajpheart.1992.262.1.H246

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  55 in total

Review 1.  Endothelial vesicles in the blood-brain barrier: are they related to permeability?

Authors:  P A Stewart
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  Evidence for the role of alveolar epithelial gp60 in active transalveolar albumin transport in the rat lung.

Authors:  T A John; S M Vogel; R D Minshall; K Ridge; C Tiruppathi; A B Malik
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

3.  Giant membrane vesicles as a model to study cellular substrate uptake dissected from metabolism.

Authors:  D P Y Koonen; W A Coumans; Y Arumugam; A Bonen; J F C Glatz; J J F P Luiken
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

Review 4.  Overcoming key technological challenges in using mass spectrometry for mapping cell surfaces in tissues.

Authors:  Noelle M Griffin; Jan E Schnitzer
Journal:  Mol Cell Proteomics       Date:  2010-06-14       Impact factor: 5.911

5.  Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes.

Authors:  Candace C Fleischer; Christine K Payne
Journal:  J Phys Chem B       Date:  2012-07-20       Impact factor: 2.991

Review 6.  The inner blood-retinal barrier: Cellular basis and development.

Authors:  Mónica Díaz-Coránguez; Carla Ramos; David A Antonetti
Journal:  Vision Res       Date:  2017-06-27       Impact factor: 1.886

7.  Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin.

Authors:  Joseph A Falcone; Therese S Salameh; Xiang Yi; Benjamin J Cordy; William G Mortell; Alexander V Kabanov; William A Banks
Journal:  J Pharmacol Exp Ther       Date:  2014-07-15       Impact factor: 4.030

8.  A direct role for serum albumin in the cellular uptake of long-chain fatty acids.

Authors:  B L Trigatti; G E Gerber
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

9.  Application of albumin-based nanoparticles in the management of cancer.

Authors:  Xinzhe Yu; Chen Jin
Journal:  J Mater Sci Mater Med       Date:  2015-11-26       Impact factor: 3.896

10.  Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging.

Authors:  Adrian Chrastina; Jan E Schnitzer
Journal:  Int J Nanomedicine       Date:  2010-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.